Effects of Corticosteroid Treatment on Mycophenolic Acid Exposure in Renal Transplant Patients-Results From the SAILOR Study
Background: Mycophenolic acid (MPA) is a potent immunosuppressive agent used in solid organ transplantation. MPA exhibits large interindividual variation in dose-normalized plasma concentrations but is nevertheless usually prescribed as a fixed dose without use of therapeutic drug monitoring (TDM)....
Saved in:
Main Authors: | Nima Nourbakhsh (Author), Jana Ekberg (Author), Karin Skov (Author), Christian Daugaard Peters (Author), Aygen Øzbay (Author), Per Lindner (Author), Niels Henrik Buus (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetil
by: Luiza Barbosa Oliveira, et al.
Published: (2017) -
The Sailor
by: Snaith, J. C. (John Collis), 1876-1936; Hottinger, W. A. [Illustrator] -
The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
by: Mohamed S. AbdElhalim, et al.
Published: (2020) -
Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability
by: Déla Golshayan, et al.
Published: (2009) -
Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients
by: Jun Zhang, et al.
Published: (2017)